You Made It to the Holy Land — Now Here’s How to Actually Buy 0DTE Puts You did it. You funded the account, passed the options approval quiz, and finally landed in the holy land that options Reddit has been hyping for years: live access to zero-days-to-expiration puts. The thrill lasts about 45 seconds before a cold realization sets in — you have no idea how to actually place the trade. ...
FDA Expected to Lift Peptide Restrictions: What Traders Need to Know Right Now The FDA is expected to lift longstanding restrictions on certain peptides, according to a report from The New York Times — and the market is already pricing in the reversal. For traders positioned in biotech, compounding pharmacy plays, or pharmaceutical sector ETFs, this is not a background news item. This is a catalyst. The expected regulatory shift would reverse a controversial crackdown that began in 2023, when the FDA moved certain peptides — including popular compounds like BPC-157, TB-500, and others used widely in anti-aging and recovery medicine — onto its “bulk drug substances” restricted list. That move hammered compounding pharmacies and sparked immediate legal challenges. Now, with the FDA expected to lift those restrictions, the sector is watching for a clean reversal with significant upside for the right plays. ...
Eli Lilly Reaches $2.75 Billion Deal with Insilico to Bring AI-Developed Drugs to Market Eli Lilly just put a $2.75 billion price tag on the future of drug discovery. The pharmaceutical giant has reached a landmark licensing and collaboration agreement with Insilico Medicine, an AI-native biotech that uses generative models to design drug candidates from scratch — and the deal signals a fundamental shift in how the world’s most valuable pharma companies are thinking about their pipelines. ...
Bitcoin Rainbow Chart Shows Price Below the “Gay Zone” — What That Signals for the Cycle The Bitcoin rainbow chart just flashed one of its rarest warnings. After a sustained drawdown, BTC’s price has slipped below the multi-colored mid-range band traders colloquially call the “gay zone” — the vibrant, ROYGBIV-colored middle section of the logarithmic regression chart that historically demarcates neutral-to-bullish territory. When price exits this zone to the downside, the historical record gets interesting fast. ...
You just got options approval. You pull up a ticker, click over to the options tab, and stare at a wall of numbers that looks like someone exported a spreadsheet from 1997. Rows, columns, colors, strange Greek letters. It is genuinely confusing the first time. This guide is going to walk you through that grid, column by column, until it makes complete sense. No fluff. No hand-waving. By the end, you will know exactly what you are looking at and how to use it to make smarter trading decisions. ...
If you’ve ever bought an options contract, watched the underlying move exactly where you expected, and still lost money, you’ve already met theta. You just might not have been formally introduced. Theta is the silent tax every options buyer pays every single day. It doesn’t care about your analysis. It doesn’t care about the news catalyst you’ve been tracking. It just keeps ticking, grinding your contract’s value down toward zero. For sellers, that same relentless clock is a paycheck. ...
Anyone Else Exhausted Watching Their Investments Swing Wildly Over Political Theater They Can’t Control? You’re not alone — and you’re not imagining it. If you’ve found yourself staring at a red portfolio screen on a Tuesday morning because a single tweet, a leaked memo, or an off-script press conference just vaporized three weeks of gains, you are in very good company. Anyone who has been investing through the past several years is exhausted by this. The market whipsaws. The headlines scream. And somewhere in the back of your head, a voice whispers: “Should I just sell everything and hide in cash?” ...
Dow Jones & NASDAQ Composite Close in -10% Correction Territory The numbers are in—and they’re uncomfortable. Both the Dow Jones Industrial Average and the NASDAQ Composite officially closed in correction territory this week, each registering drawdowns exceeding 10% from their most recent all-time highs. For retail traders watching their portfolios bleed red, the instinct is to panic. For experienced traders, this is a moment to think clearly, act deliberately, and—if positioned correctly—to profit. ...
Both the Dow Jones Industrial Average and the NASDAQ Composite have officially closed in correction territory, each falling more than 10% from their recent highs. For investors who have been watching their portfolios shrink day after day, the question isn’t just “why is this happening” but “what do I do now.” This article breaks down the forces behind the March 2026 correction, places the drawdown in its proper historical context, and outlines specific, actionable strategies — including options plays — that active investors and traders are deploying right now. ...
Introduction: Why Options Matter in 2026 Options trading remains one of the most profitable yet misunderstood aspects of the financial markets. As volatility continues to shape market dynamics in 2026, understanding and deploying sophisticated options strategies has become essential for serious traders. Whether you’re hedging an existing portfolio, generating income, or speculating on directional moves, options provide the flexibility and leverage needed to adapt to rapidly changing market conditions. In this comprehensive guide, we’ll explore the top options trading strategies that work in 2026’s market environment, from basic spreads to advanced volatility plays. We’ll focus on practical execution, risk management, and the tools you’ll need to succeed. ...